Life Science Investor Mandates
(Feb. 7 - Feb. 13
)
|
|
|
|
|
Invests Up to $15M in Early-Stage Life Science Companies, Open to All Subsectors and Indications
|
|
Seeks to Partner with First-in-Class Therapeutic Assets in Various Indications
|
|
Invests in Devices, Diagnostics, and Digital Health Companies with a Newly Raised Fund
|
|
Actively Seeking Innovative Therapeutics that Address Unmet Need, with Focus on Europe-Based Companies
|
|
|
 |
|
By Lucy Parkinson, VP of Investor Research, LSN
 LSN's one overriding message is that entrepreneurs need to look globally for capital. That's the ethos that guides RESI, and our Investor Research team maintain a network of investors based all over the world that regularly attend our RESI partnering events to meet with emerging CEOs. RESI's first ever event in Europe is already attracting a high level of investor interest - Click here to see some of the firms that are confirmed to attend RESI Europe to look for early stage opportunities. Due to RESI's laser focus on investment, there's no more efficient way to connect with global capital - entrepreneurs can book up to 16 investor meetings in one day, and RESI's unique partnering system helps get their messages to the most relevant investors in their space.
In addition to meetings, RESI provides two tracks of investor panels that help entrepreneurs understand how life science investors think, what they're looking for, and what makes a deal go or no-go for them. RESI's Early Stage Therapeutics panel will cover all these issues and more for biotech entrepreneurs. The participants are:
- Sara Secall (Investment Director, Inveready Asset Management)
- Marco Boorsma (Partner, Forbion)
- Harvey Gross (Partner, Apollo Ventures)
- Martin Pfister (Senior Investment Manager: Life Sciences, High-Tech Gründerfonds)
- Roel Bulthuis (Managing Director, INKEF Capital)
|
 |
 |
|
Fundraising & Valuation Boot Camp in Europe
February 28th - Heidelberg
WHEN:
28 February, 09:00 am - 12:30 pm
WHERE:
Conference Center Technology Park, Heidelberg
|
|
|
By Karen Deyo, Investor Research Analyst, LSN
 LSN first introduced the Innovators' Pitch Challenge at RESI Boston in September of 2018. This new aspect of RESI was designed to give the earliest stage companies spinning out from incubators, accelerators and universities a platform to pitch to a panel of investors. The aim of the RESI Innovators' Pitch Challenge was to give these companies a chance to practice their investment pitch and get valuable feedback from real investors. To get a perspective on the value of participating in the Innovators' Pitch Challenge, I spoke to Scott Stout, CEO of MedVector Clinical Trials (one of the companies selected to participate in the West Coast Innovators' Pitch Challenge at RESI San Francisco), and Ravi Mistry, an angel investor part of TiE Silicon Valley Angels, who was part of the investor panel at the same event.
Especially for those earliest stage companies just starting their first major fundraise, the ability to practice your pitch before a panel of investors can be helpful. The questions asked by the experienced investor panelists can help the participants anticipate what investors will ask when pitching to them, as well as helping you identify what areas of your pitch may need to be clarified...
|
|
|
By Jessica Yang, Senior Investor Research Analyst & Asia BD, LSN
 Life Science Nation invites all early stage life science/healthcare companies to apply to the RESI Europe Innovation Challenge to showcase their technologies at our upcoming RESI partnering event in Vienna! Companies can apply to the Innovation Challenge free of charge. Once the applications close (the deadline is February 20th!), the LSN scientific review team selects the top 30 to compete. Innovation Challenge Finalists present a poster in the exhibition hall during RESI, as well as receiving additional exposure in the printed program guide and the LSN newsletter. All attendees receive 'RESI cash' which they can 'invest' in their favorite companies - the top three companies will receive prizes during the cocktail hour and will be announced to LSN's worldwide following! Here are some features of Innovation Challenge:
- Finalists will be highlighted in multiple media outlets:
- Announcement in weekly LSN Newsletter with readership of 20,000+
- Featured on RESI Conference website
- Featured in printed and online RESI Vienna program guide
- Finalists will present a poster of their technology at the conference
- All conference attendees will have the chance to "invest" RESI Cash in their favorite technologies
- Top 3 winners will be announced during the cocktail reception and receive prizes/ RESI tickets to future RESI Conferences
- It is FREE to apply!
|
|
|
|
|
|
|
Created & Produced by
|
 |
|
|
|
